Earth Science Tech, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OID
Earth Science Tech, Inc. (ETST) announced its fiscal year 2026 results, showing an 8% increase in revenue to $35.7 million, driven by strong demand in its compounding pharmacy and telemedicine segments.
OID
Earth Science Tech, Inc. announced a significant increase in revenue and net income for the fiscal year ended March 31, 2025, fueled by strategic acquisitions and expansion in its healthcare and real estate sectors.
OID
Earth Science Tech, Inc. reports a significant increase in revenue and a shift to net profit for the fiscal year ending March 31, 2024, driven by its compounding pharmacy and telemedicine operations.
OID
Earth Science Tech, Inc. has restated its prior year financial statements due to errors in recording and reporting Goodwill, primarily related to the acquisition of RxCompound.